Literature DB >> 27491503

Macrophage Phenotype in Liver Injury and Repair.

Y-Y Sun1,2,3, X-F Li1,2,3, X-M Meng1,2,3, C Huang1,2,3, L Zhang1,2,3, J Li1,2,3.   

Abstract

Macrophages hold a critical position in the pathogenesis of liver injury and repair, in which their infiltrations is regarded as a main feature for both acute and chronic liver diseases. It is noted that, based on the distinct phenotypes and origins, hepatic macrophages are capable of clearing pathogens, promoting/or inhibiting liver inflammation, while regulating liver fibrosis and fibrolysis through interplaying with hepatocytes and hepatic stellate cells (HSC) via releasing different types of pro- or anti-inflammatory cytokines and growth factors. Macrophages are typically categorized into M1 or M2 phenotypes by adapting to local microenvironment during the progression of liver injury. In most occasions, M1 macrophages play a pro-inflammatory role in liver injury, while M2 macrophages exert an anti-inflammatory or pro-fibrotic role during liver repair and fibrosis. In this review, we focused on the up-to-date information about the phenotypic and functional plasticity of the macrophages and discussed the detailed mechanisms through which the phenotypes and functions of macrophages are regulated in different stages of liver injury and repair. Moreover, their roles in determining the fate of liver diseases were also summarized. Finally, the macrophage-targeted therapies against liver diseases were also be evaluated.
© 2016 The Foundation for the Scandinavian Journal of Immunology.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27491503     DOI: 10.1111/sji.12468

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  35 in total

1.  Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome.

Authors:  Yimei Liu; Ninghua Liu; Yujing Liu; Hongyu He; Zhe Luo; Wenjun Liu; Nan Song; Minjie Ju
Journal:  J Clin Transl Hepatol       Date:  2021-08-19

2.  Myeloid HO-1 modulates macrophage polarization and protects against ischemia-reperfusion injury.

Authors:  Min Zhang; Kojiro Nakamura; Shoichi Kageyama; Akeem O Lawal; Ke Wei Gong; May Bhetraratana; Takehiro Fujii; Dawoud Sulaiman; Hirofumi Hirao; Subhashini Bolisetty; Jerzy W Kupiec-Weglinski; Jesus A Araujo
Journal:  JCI Insight       Date:  2018-10-04

3.  Fibrotic liver has prompt recovery after ischemia-reperfusion injury.

Authors:  Takanori Konishi; Rebecca M Schuster; Holly S Goetzman; Charles C Caldwell; Alex B Lentsch
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-01-21       Impact factor: 4.052

4.  M2-like macrophages in the fibrotic liver protect mice against lethal insults through conferring apoptosis resistance to hepatocytes.

Authors:  Li Bai; Xin Liu; Qingfen Zheng; Ming Kong; Xiaohui Zhang; Richard Hu; Jinli Lou; Feng Ren; Yu Chen; Sujun Zheng; Shuang Liu; Yuan-Ping Han; Zhongping Duan; Stephen J Pandol
Journal:  Sci Rep       Date:  2017-09-05       Impact factor: 4.379

5.  Selective targeting of tumor associated macrophages in different tumor models.

Authors:  Bianca Kakoschky; Thomas Pleli; Christian Schmithals; Stefan Zeuzem; Bernhard Brüne; Thomas J Vogl; Horst-Werner Korf; Andreas Weigert; Albrecht Piiper
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

6.  Macrophages induce the expression of lncRNA ATB via the secretion of TGF-β to relieve ischemia-reperfusion injury in cardiomyocytes.

Authors:  Hong Lin; Wen-Sheng Xu; Xiong-Wei Liu; Zhi Wang; Jiao Yan; Tao Zhang
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

Review 7.  Extracellular vesicle activities regulating macrophage- and tissue-mediated injury and repair responses.

Authors:  Qian Hu; Christopher J Lyon; Jesse K Fletcher; Wenfu Tang; Meihua Wan; Tony Y Hu
Journal:  Acta Pharm Sin B       Date:  2020-12-19       Impact factor: 11.413

8.  Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells.

Authors:  Qiu-Ju Han; Yong-Liang Mu; Hua-Jun Zhao; Rong-Rong Zhao; Quan-Juan Guo; Yu-Hang Su; Jian Zhang
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

Review 9.  Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction.

Authors:  Cornelius Engelmann; Joan Clària; Gyongyi Szabo; Jaume Bosch; Mauro Bernardi
Journal:  J Hepatol       Date:  2021-07       Impact factor: 30.083

10.  Identification of pro-inflammatory CD205+ macrophages in livers of hepatitis B virus transgenic mice and patients with chronic hepatitis B.

Authors:  Liang Yong; Minmin Li; Yimin Gao; Yanru Deng; Wenbin Liu; Dake Huang; Cuiping Ren; Miao Liu; Jijia Shen; Xin Hou
Journal:  Sci Rep       Date:  2017-04-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.